Expression and clinical significance of antigen presentation components beta-2 microglobulin, HLA class I heavy chains, and HLA class II in non-small cell lung cancer (NSCLC).

被引：1
|
作者：
Datar, Ila
Villarroel-Espindola, Franz
Henick, Brian S.
Syrigos, Konstantinos N.
Toki, Maria
Rimm, David L.
Ferrone, Soldano
Herbst, Roy S.
Schalper, Kurt A.
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Natl & Kapodistrian Univ Athens, Sch Med, Athens, Greece
[3] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.12015
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
12015
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Retinoblastoma protein rescue of HLA class II mRNA IFN-gamma inducibility in non-small cell lung carcinoma (NSCLC) cells
    Lu, YM
    Boss, JM
    Hu, SX
    Xu, HJ
    Blanck, G
    HUMAN IMMUNOLOGY, 1996, 47 (1-2) : P66 - P66
  • [32] Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism
    Koukourakis, Ioannis M.
    Giatromanolaki, Alexandra
    Mitrakas, Achilleas
    Koukourakis, Michael I.
    CELLULAR IMMUNOLOGY, 2022, 373
  • [33] Clinical significance of cannabinoid receptor CB2 expression in non-small cell lung cancer (NSCLC)
    Tsoukalas, N. G.
    Giaginis, C.
    Alexandrou, P.
    Liontos, M.
    Tolia, M.
    Kiakou, M.
    Sfiniadakis, I.
    Kavantzas, N.
    Patsouris, E.
    Theocharis, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S1115 - S1115
  • [34] MAP1LC3C repression reduces CIITA- and HLA class II expression in non-small cell lung cancer
    Barbeau, Lydie M. O.
    Beelen, Nicky A.
    Savelkouls, Kim G.
    Keulers, Tom G. H.
    Wieten, Lotte
    Rouschop, Kasper M. A.
    PLOS ONE, 2025, 20 (02):
  • [35] Clinical significance of annexin II expression in human non-small cell lung cancer
    Jia, Jin-Wei
    Li, Kun-Lin
    Wu, Jin-Xing
    Guo, Shu-Liang
    TUMOR BIOLOGY, 2013, 34 (03) : 1767 - 1771
  • [36] Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
    N. Ramnath
    D. Tan
    Q. Li
    B. L. Hylander
    P. Bogner
    L. Ryes
    S. Ferrone
    Cancer Immunology, Immunotherapy, 2006, 55 : 891 - 899
  • [37] Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
    Ramnath, N
    Tan, D
    Li, Q
    Hylander, BL
    Bogner, P
    Ryes, L
    Ferrone, S
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2006, 55 (08) : 891 - 899
  • [38] LACKING PROGNOSTIC-SIGNIFICANCE OF BETA-2-MICROGLOBULIN, MHC CLASS-I AND CLASS-II ANTIGEN EXPRESSION IN BREAST CARCINOMAS
    WINTZER, HO
    BENZING, M
    VONKLEIST, S
    BRITISH JOURNAL OF CANCER, 1990, 62 (02) : 289 - 295
  • [39] Clinical significance of high expression of proliferating cell nuclear antigen in non-small cell lung cancer
    Ye, Xiaolan
    Ling, Bai
    Xu, Hanrong
    Li, Gongqi
    Zhao, Xinguo
    Xu, Jiangyan
    Liu, Jun
    Liu, Liangeng
    MEDICINE, 2020, 99 (16) : E19755
  • [40] Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
    Jiang, Cindy Y.
    Zhao, Lili
    Green, Michael D.
    Ravishankar, Shashidhar
    Towlerton, Andrea M. H.
    Scott, Anthony J.
    Raghavan, Malini
    Cusick, Matthew F.
    Warren, Edus H.
    Ramnath, Nithya
    SCIENTIFIC REPORTS, 2024, 14 (01)
12345